Henoch-Schönlein nephritis: a nationwide study.
OBJECTIVE
The aim of this retrospective study was to evaluate the presentation, clinical and pathological manifestations and outcome of the Henoch-Schönlein purpura (HSP) nephritis in children.


METHODS
Clinical and laboratory data of 443 children with HSP nephritis aged between 3 and 16 years from 16 pediatric nephrology reference centers were analyzed retrospectively. The biopsy findings were graded according to the classification developed by the International Study of Kidney Disease in Children (ISKDC).


RESULTS
Renal biopsy was performed in 179 of the patients with HSP nephritis. The most common presenting clinical finding in patients who were biopsied was nephrotic range proteinuria (25%) which was followed by nephritic-nephrotic syndrome (23.5%). The biopsy findings according to the ISKDC were as follows: class I: 8.3%; II: 44.1%; III: 36.3%; IV: 6.7%; V: 3.3%; VI: 1.1%. All of the patients who developed end-stage renal disease had nephritic-nephrotic syndrome at presentation. Of 443 patients, 87.2% had a favorable outcome and 12.8% had an unfavorable outcome. The overall percentage of children who developed end-stage renal disease at follow-up was 1.1%. Logistic regression analysis did not show any association of initial symptoms and histology with outcome.


CONCLUSIONS
In the presented cohort, the presence of crescents in the first biopsy or presenting clinical findings did not seem to predict the outcome of HSP nephritis in children. We conclude that children with HSP nephritis even with isolated microscopic hematuria and/or mild proteinuria should be followed closely.
Gazi University, Department of Pediatric Nephrology, Ankara, Turkey.
O
O
Soylemezoglu
O
O
Ozkaya
S
S
Ozen
A
A
Bakkaloglu
R
R
Dusunsel
H
H
Peru
A
A
Cetinyurek
N
N
Yildiz
O
O
Donmez
N
N
Buyan
S
S
Mir
N
N
Arisoy
A
A
Gur-Guven
H
H
Alpay
M
M
Ekim
N
N
Aksu
A
A
Soylu
F
F
Gok
H
H
Poyrazoglu
F
F
Sonmez
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D015897:Comorbidity; D005260:Female; D006801:Humans; D011695:IgA Vasculitis / Q000453:epidemiology* / Q000473:pathology*; D015994:Incidence; D008297:Male; D009393:Nephritis / Q000453:epidemiology* / Q000473:pathology*; D015203:Reproducibility of Results; D018570:Risk Assessment; D012307:Risk Factors; D012680:Sensitivity and Specificity; D014421:Turkey / Q000453:epidemiology